PNMA2 and amyotrophic lateral sclerosis: Down-regulation of PNMA2, whose product is a target of neurodegenerative autoimmune responses, is reminiscent of a PNMA2-autoantibody-associated encephalitis patient with ALS symptoms, who presented with inflammation in cortex and spinal-cord grey matter [86,87].